Available Guidance and Best Practices for Conducting Forced Degradation Studies

Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.

Related Content:

Regulatory/GMP ComplianceQuality SystemsRegulatory Authority ActionsPharmaceutical Technology-02-02-2002

Drug Solutions Podcast: FDA Weighs in on Advancing the Science of Pharmaceutical Manufacturing

FDA Launches Accelerated Rare Disease Cures Program

FDA Publishes Draft Guidance on Quality Assessments